Donald D. Mooney
Directeur/Membre du Conseil chez NOVX Systems, Inc.
Profil
Donald D.
Mooney is currently a Director at NOVX Systems, Inc. He was previously the President & Chief Executive Officer at ProteoGenix, Inc. from 2007 to 2012.
He also served as the Chief Executive Officer at MicroPhage, Inc. and President at Bausch & Lomb, Inc. In addition, he was the Vice President-Sales & Marketing at Johnson & Johnson from 1996 to 1999 and a Principal at Chiron Diagnostics Corp.
from 1978 to 1996.
He was also the Chief Operating Officer & Vice President at Quest Diagnostics Infectious Disease, Inc. from 2004 to 2007.
He received his undergraduate degree from Southern Illinois University.
Postes actifs de Donald D. Mooney
| Sociétés | Poste | Début |
|---|---|---|
NOVX Systems, Inc.
 NOVX Systems, Inc. Medical SpecialtiesHealth Technology NOVX Systems, Inc. develops drug screening solutions. Its products include PatientVu, PatientVu Pain and UDS Tests and Dips. The company was founded by Tino Alavie in March 2001 and is headquartered in Richmond Hill, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Donald D. Mooney
| Sociétés | Poste | Fin |
|---|---|---|
ProteoGenix, Inc.
 ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | President | 29/03/2012 |
Quest Diagnostics Infectious Disease, Inc.
 Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Directeur des opérations | 01/03/2007 |
| JOHNSON & JOHNSON | Sales & Marketing | 01/01/1999 |
Chiron Diagnostics Corp.
 Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Corporate Officer/Principal | 01/01/1996 |
MicroPhage, Inc.
 MicroPhage, Inc. Medical/Nursing ServicesHealth Services MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO. | Directeur Général | - |
Formation de Donald D. Mooney
| Southern Illinois University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 7 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Chiron Diagnostics Corp.
Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Health Technology |
NOVX Systems, Inc.
NOVX Systems, Inc. Medical SpecialtiesHealth Technology NOVX Systems, Inc. develops drug screening solutions. Its products include PatientVu, PatientVu Pain and UDS Tests and Dips. The company was founded by Tino Alavie in March 2001 and is headquartered in Richmond Hill, Canada. | Health Technology |
ProteoGenix, Inc.
ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Health Technology |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Commercial Services |
MicroPhage, Inc.
MicroPhage, Inc. Medical/Nursing ServicesHealth Services MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO. | Health Services |
| DRM Management & Associates, Inc. |
